- Home
- CELH vs LNTH Comparison
CELH vs LNTH Comparison
Compare CELH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELH
- LNTH
- Stock Information
- Founded
- CELH 2004
- LNTH 1956
- Country
- CELH United States
- LNTH United States
- Employees
- CELH N/A
- LNTH N/A
- Industry
- CELH Beverages (Production/Distribution)
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CELH Consumer Staples
- LNTH Health Care
- Exchange
- CELH Nasdaq
- LNTH Nasdaq
- Market Cap
- CELH 7.5B
- LNTH 7.5B
- IPO Year
- CELH N/A
- LNTH 2015
- Fundamental
- Price
- CELH $36.00
- LNTH $97.39
- Analyst Decision
- CELH Buy
- LNTH Strong Buy
- Analyst Count
- CELH 17
- LNTH 6
- Target Price
- CELH $45.53
- LNTH $129.83
- AVG Volume (30 Days)
- CELH 9.2M
- LNTH 790.8K
- Earning Date
- CELH 05-06-2025
- LNTH 05-01-2025
- Dividend Yield
- CELH N/A
- LNTH N/A
- EPS Growth
- CELH N/A
- LNTH N/A
- EPS
- CELH 0.45
- LNTH 4.36
- Revenue
- CELH $1,355,630,000.00
- LNTH $1,533,910,000.00
- Revenue This Year
- CELH $34.40
- LNTH $6.59
- Revenue Next Year
- CELH $17.18
- LNTH $11.80
- P/E Ratio
- CELH $79.43
- LNTH $22.30
- Revenue Growth
- CELH 2.85
- LNTH 18.32
- 52 Week Low
- CELH $21.10
- LNTH $58.46
- 52 Week High
- CELH $98.85
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- CELH 67.35
- LNTH 50.29
- Support Level
- CELH $33.19
- LNTH $93.61
- Resistance Level
- CELH $37.52
- LNTH $98.98
- Average True Range (ATR)
- CELH 1.98
- LNTH 3.72
- MACD
- CELH 0.31
- LNTH -0.77
- Stochastic Oscillator
- CELH 85.34
- LNTH 36.37
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.